NHS Choices ‘Behind the Headlines’ assessment of press reports that a stem cell trial for an eye condition is to go ahead

Source: NHS Choices
Area: News
The 'Behind the Headlines' service from NHS Choices has featured a quality assessment of press reports that doctors at Moorfields Eye Hospital have been "given the go-ahead" to carry out Europe's first clinical trial using embryonic stem cells, in patients with Stargardt's macular dystrophy.  The assessment addresses the following questions:   . What is Stargardt's disease? . What are embryonic stem cells? . How will the trial be performed? . What is the purpose of the trial? . When will we know if it has been successful?   Please see (Read more...)

Full Story →